1 Background

Adenomatoid tumor is a very rare benign neoplasm affecting mainly female and male genital tracts [1,2,3]. However, other extra-genital organs can be involved by adenomatoid tumors, such as adrenal gland, pleura, mediastinum, mesentery, omentum, liver and gastrointestinal tract [4,5,6,7,8]. The name “adenomatoid tumor” was first introduced by Golden and Ash as the origin of these tumors was controversial in 1945 when they reported their study [9]. It is now well established that adenomatoid tumors have a mesothelial origin as supported by many immunohistochemical and other molecular studies [1, 10]. In fact, although many locations have been reported, adenomatoid tumors usually develop next to serosal surfaces (mesothelial cell lining) of the involved organs.

Adenomatoid tumors of the male genital tract involve mainly the paratesticular region and the epididymis, rarely they develop within the testicular parenchyma [11,12,13,14,15,16]. They mimic many differential diagnoses as the preoperative diagnostic modalities lack specificity (imaging techniques mainly), and the definitive diagnosis relies on the histopathological analysis of the resected specimens. The current literature offers only some case reports and short series of adenomatoid tumors [1,2,3, 10].

We report herein additional case of a right epididymal adenomatoid tumor in a 47-year-old patient that presented with chronic testicular pain. The diagnosis was made by histopathological analysis of the resected lesion and the patient recovered well after surgery.

2 Case presentation

A 47-year-old patient presented for chronic mild pain of the right testis evolving for months. The patient had unremarkable medical history and he had no chronic diseases such as diabetes, high blood pressure or other chronic illnesses. On physical examination, he had good general health conditions, the urological examination shows a palpable right intrascrotal nodule of 10 mm in greatest diameter. The nodule was painful, mobile with firm consistency. The contralateral testis was normal. There was no inguinal mass or lymphadenopathy. The pelvis, abdomen and thorax were normal on physical examination. The laboratory investigations were within normal limits (blood, liver and renal function tests). Serological tests of tumor markers were also within normal range: serum alpha fetoprotein, beta human chorionic gonadotrophin, alkaline phosphatase and prostate-specific antigen (PSA). Scrotal ultrasonography showed a well-circumscribed predominantly hyperechoic intrascrotal nodule of 10 × 10 mm in the right epididymal head with heterogeneous echostructure. The other testicular components were normal. The left testis was normal without any lesion. There were no other lesions in the pelvis or in other parts of the abdominal cavity. A surgical treatment was decided. A trans-scrotal approach was performed, the surgical exploration revealed a well-defined right 10 mm epididymal nodule without involvement of the testicular parenchymal tissue (Fig. 1). A testicular-preserving surgery was performed with the complete resection of the nodule that has been sent for histopathological analysis. The resected specimen measured 10 × 10 mm with a firm consistency and a whitish homogeneous whorled cut surface. The histopathological analysis showed a well-circumscribed tumor with microcystic and trabecular architecture made of small interconnected tubules and cysts lined by flattened cells with prominent vacuolization in some areas with a signet-ring appearance (Fig. 2). Thread-like bridging strands were observed in some tumor parts (Fig. 3). The nuclei were oval with bland appearance and small nucleoli. There were no atypia, mitoses or necrosis. The tumor stroma was fibrous with scattered inflammatory lymphocytes sometimes arranged in follicles (Fig. 4). These histopathological features were characteristic of an adenomatoid tumor. The postoperative course was uneventful and the patient was discharged from hospital. Four months after surgical treatment, the patient has no sign of the disease.

Fig. 1
figure 1

The operative view of the tumor showing a well-defined nodule in the head of the epididymis (black arrow)

Fig. 2
figure 2

The microscopic image showing a well-circumscribed tumor with microcystic and trabecular architecture made of small interconnected tubules and cysts (hematoxylin and eosin stain × 40)

Fig. 3
figure 3

Microscopic image: Prominent vacuolated cells with characteristic thread-like bridging strands (black arrow) (hematoxylin and eosin stain × 400)

Fig. 4
figure 4

Microscopic image: The microcystic trabeculae and spaces are lined by flattened cells with prominent vacuolization disposed within fibrous stroma with scattered inflammatory lymphocytes sometimes arranged in follicles (black arrow) (hematoxylin and eosin stain × 100)

3 Discussion

Adenomatoid tumor is a rare benign neoplasm that affects mainly paratesticular regions accounting for a third of all neoplasms of this anatomical area [16, 17]. The epididymal tail is the most location of this tumor, the epididymal head is rarely affected. Usually, patients’ age ranges from 20 to 66 years with a mean age of 46–50 years, the occurrence in children being very uncommon [2, 3, 17, 18]. Unlike their female genital tract counterpart that are commonly found incidentally, male genital tract adenomatoid tumors are usually symptomatic lesions presenting with chronic testicular pain or swelling [2, 3]. Our current case has a classic epidemiological and clinical presentation, a part from the tumor location involving epididymal head as the tail is the most affected part of the epididymis in previous reports [1].

Ultrasonography (US) is widely used to investigate intrascrotal and paratesticular tumors. Adenomatoid tumors appear as a well-defined homogeneous hypoechoic or hyperechoic nodule with no increased blood flow on color Doppler US [11, 16, 19, 20]. Adenomatoid tumors with intratesticular growth, especially when arising in tunica albuginea, tunica vaginalis or the rete testis, mimic malignant testicular tumors [12, 13, 15, 16]. The computed tomography scan (CT scan) or the magnetic resonance imaging (MRI) is useful in cases where malignancy is suspected as these techniques allow better assessment of the tumor and its relation with the surrounding tissues [11]. In our patient, there was no clinical suspicion of malignancy and the US assessment showed a predominantly hyperechoic lesion suggesting an epididymal cyst.

Testicular adenomatoid tumors are usually well-circumscribed lesions lacking fibrous capsule, arising in the epididymis, rarely in testicular tunica with secondary involvement of the parenchyma [1]. They present as firm nodules of around 1 cm in greatest diameter, rarely exceeding 2 cm [2, 3]. The cut surface is homogeneous, whitish sometimes whorled [2]. Our case has characteristic gross features of adenomatoid tumor: a well-circumscribed firm nodule measuring 1 cm with homogeneous whitish whorled cut surface.

On microscopic examination, adenomatoid tumors appear with microcystic, angiomatoid or trabecular architecture, solid or macrocystic patterns are rarely reported [1, 9]. The tumor’s stroma is usually fibrous with scattered lymphocytes, but sometimes the stroma may have prominent smooth muscle tissue, leading some authors to name the lesion as leiomyoadenomatoid tumor [1, 19,20,21]. The cells vary from flattened to vacuolated with abundant cytoplasm. The nuclei are oval, bland, centrally located with a small nucleolus [1,2,3, 9]. These vacuolated cells are very characteristic of adenomatoid tumors [9]. They contain prominent cytoplasmic vacuoles with only thin cytoplasmic strands connecting them, referred to as “thread-like bridging strands” [1, 9]. These strands bridge the lumina of the tubular and slit-like spaces of the tumor [1]. The vacuolated cells also appear as signet-ring cells especially when cells have small vacuoles and are arranged in trabeculae, posing a serious diagnostic challenge with metastatic carcinomas. On immunohistochemical analysis, adenomatoid tumors express classic mesothelial markers such as pancytokeratin, WT1 (Wilm’s tumor protein-1) calretinin, D2-40 or HBME-1 (human bone marrow endothelial cell marker-1), the proliferative index (Ki-67) being less than 10% [1,2,3]. In our current case, the definitive diagnosis was reached without the need for immunohistochemistry as morphological features were characteristic: a well-circumscribed epididymal nodule with predominantly microcystic architecture with bland-looking cells and prominent vacuolated cells showing the characteristic thread-like bridging strands. However, in certain instances especially in unusual locations (intratesticular parenchymal growth), infarcted tumors with reactive atypias, predominantly solid or macrocystic architectures, many differential diagnoses could be evoked and immunohistochemical analysis should be required. Table 1 summarizes some differential diagnoses of testicular adenomatoid tumors. The most important differential diagnosis to rule out is the malignant mesothelioma. Diagnostic challenges appear especially with well-differentiated mesothelioma and with malignant mesothelioma with adenomatoid tumor features. Malignant mesotheliomas have classically ill-defined borders with substantial cellular atypia and mitoses. Immunohistochemical markers that can be useful in these instances are BAP1 (BRCA1-associated protein-1) that is positive in adenomatoid tumors and negative in malignant mesothelioma, L1CAM (L1 cell adhesion molecule) also positive in adenomatoid tumors and negative in malignant mesothelioma [1, 10, 22, 23]. Also, CK5/6 (cytokeratin 5/6) is classically strongly positive in malignant mesothelioma while negative or focally positive in adenomatoid tumors [1, 22]. The other classic mesothelial markers, like WT1, calretinin, D2-40 and HBME-1, have no discriminative value as they are positive in both malignant mesothelioma and adenomatoid tumors [1]. Vascular lesions (hemangioma and lymphangioma) are very rare in the testis, their diagnosis can be easily ruled out by the negative immunostaining with mesothelial markers and their positive staining with endothelial markers like CD34 (cluster of differentiation 34), CD31, ERG, factor VIII-related antigen [1,2,3, 10, 11]. Of note lymphangioma express D2-40 like other mesothelial tumors [1]. Spermatocele is a common epididymal cystic lesion resulting from dilatation of rete testis or epididymal efferent ductules by obstructive mechanisms [24,25,26]. Predominantly, cystic adenomatoid tumor may mimic spermatocele clinically, radiologically and histopathologically. However, spermatocele does not express mesothelial markers but express epithelial markers of epididymal ductules such as CK7, PAX8 and androgen receptor (AR) [27]. Adenomatoid tumors arising in tunica albuginea or tunica vaginalis with intratesticular growth are very rare and pose diagnostic challenge with primary testicular germ cell tumors [12, 13, 28]. On microscopic analysis, the microcystic architecture and vacuolated cells of adenomatoid tumors can be mistaken for yolk sac tumor; however, this tumor shows sometimes characteristic perivascular arrangement of tumor cells called Schiller–Duval bodies, and they express SALL4, alpha feto-protein (AFP), glypican 3, CDX2 (caudal-related homeobox gene 2) with negative mesothelial markers on immunohistochemistry [1, 13].

Table 1 Main differential diagnoses of testicular adenomatoid tumor

The origin of adenomatoid tumors has been controversial previously, but now it is well established that they are of mesothelial origin as they express phenotypic markers related to mesothelial cells [1,2,3, 9]. The pathogenesis of adenomatoid tumors is not well understood. Several cases have been reported in immunocompromised patients treated for autoimmune diseases or organs transplantation or HIV (human immunodeficiency virus) infection [1, 10]. Recently, a study by Goode et al. has tried to investigate the association of adenomatoid tumors of the male and female genital tract with immune dysregulation and found that they are genetically defined by TRAF7 mutation, a member of the family of tumor necrosis factor receptor-associated factors (TRAFs) that drives aberrant NF-kB pathway activation [10]. TRAF7 encodes an E3 ubiquitin ligase that has been implicated in regulation of a number of critical immunomodulatory signaling pathways involving NF-kB (nuclear factor-kappa B), illustrating in part the link between adenomatoid tumors and immune dysregulation [10]. Our patient had no reported immune disease, supporting the fact that other causative mechanisms may be involved. In fact in the study reported by Goode et al., only 40% of their patients with available clinical history had a history of immune dysregulation [10].

Adenomatoid tumors are benign neoplasms with no reported malignant transformation or potential recurrence after complete surgical resection [2, 3, 11]. Unnecessary orchidectomy should be avoided and surgery ideally limited to excisional biopsy of the lesion through inguinal or scrotal approach [11, 19, 20]. In our case, the preoperative diagnosis was epididymal cyst and excision of the lesion was performed with testicular-preserving surgery. However, tumors with intratesticular growth have been managed aggressively by orchidectomy [12, 13, 18, 28].

4 Conclusion

Testicular adenomatoid tumors are very rare benign neoplasms. They pose diagnostic challenges and the definitive diagnosis relies on the histopathological analysis of the resected specimens. Adenomatoid tumors arising in epididymis are managed by excisional biopsy with testis-sparing surgery avoiding unnecessary orchidectomy.